Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract and wound healing
By accessing this site, you confirm that you are a qualified researcher or institution representative and agree to use all materials in accordance with applicable laws, regulations, and safety guidelines
Psychol Rev (2019) 126:791816
The 24-week phase 2b study did not reach statistical significance on its primary weight endpoint, and the developer ended the obesity programme in 2007 [2]
BPC-157 is supplied in a 10mg lyophilised single-vial format (3ml vial), subject to stock availability
Certain medications, including specific antiepileptics and tuberculosis drugs, can interfere with vitamin B6 metabolism, potentially causing a deficiency